DAA2689 |
Hypomethylation of C3orf18 is positively correlated with age |
C3orf18 |
— |
blood |
Human |
|
DAA2753 |
Hypomethylation of C3orf9 is positively correlated with age |
POGLUT1 |
— |
blood |
Human |
|
DAA2691 |
Hypomethylation of CBX7 is positively correlated with age |
CBX7 |
— |
blood |
Human |
|
DAA2694 |
Hypomethylation of CD274 is positively correlated with age |
CD274 |
— |
blood |
Human |
|
DAA2654 |
Hypomethylation of CD4 is positively correlated with age |
CD4 |
— |
blood |
Human |
|
DAA2698 |
Hypomethylation of CHRNE is positively correlated with age |
CHRNE |
— |
blood |
Human |
|
DAA2699 |
Hypomethylation of CHST13 is positively correlated with age |
CHST13 |
— |
blood |
Human |
|
DAA2700 |
Hypomethylation of CLCN6 is positively correlated with age |
CLCN6 |
— |
blood |
Human |
|
DAA2701 |
Hypomethylation of COL8A2 is positively correlated with age |
COL8A2 |
— |
blood |
Human |
|
DAA2702 |
Hypomethylation of CSNK1D is positively correlated with age |
CSNK1D |
— |
blood |
Human |
|
DAA2703 |
Hypomethylation of CTSZ is positively correlated with age |
CTSZ |
— |
blood |
Human |
|
DAA2704 |
Hypomethylation of CX3CL1 is positively correlated with age |
CX3CL1 |
— |
blood |
Human |
|
DAA2774 |
Hypomethylation of DKFZP566N034 is positively correlated with age |
TMEM163 |
— |
blood |
Human |
|
DAA2708 |
Hypomethylation of EDARADD is positively correlated with age |
EDARADD |
— |
blood |
Human |
|
DAA2635 |
Hypomethylation of EPHX2 is positively correlated with age |
EPHX2 |
— |
blood |
Human |
|
DAA2711 |
Hypomethylation of F5 is positively correlated with age |
F5 |
— |
blood |
Human |
|
DAA2621 |
Hypomethylation of FGF8 is positively correlated with age |
FGF8 |
— |
blood |
Human |
|
DAA2638 |
Hypomethylation of FIGN is positively correlated with age |
FIGN |
— |
blood |
Human |
|
DAA2757 |
Hypomethylation of FLJ10945 is positively correlated with age |
PRR34 |
— |
blood |
Human |
|
DAA2690 |
Hypomethylation of FLJ36268 is positively correlated with age |
C9orf139 |
— |
blood |
Human |
|
DAA2620 |
Hypomethylation of FOXP1 is positively correlated with age |
FOXP1 |
— |
blood |
Human |
|
DAA2715 |
Hypomethylation of FUT3 is positively correlated with age |
FUT3 |
— |
blood |
Human |
|
DAA2716 |
Hypomethylation of GBP1 is positively correlated with age |
GBP1 |
— |
blood |
Human |
|
DAA2719 |
Hypomethylation of GIT1 is positively correlated with age |
GIT1 |
— |
blood |
Human |
|
DAA2636 |
Hypomethylation of GPR128 is positively correlated with age |
GPR128 |
— |
blood |
Human
|
DAA2659 |
Hypomethylation of HOXB5 is positively correlated with age |
HOXB5 |
— |
blood |
Human |
|
DAA2660 |
Hypomethylation of HOXB6 is positively correlated with age |
HOXB6 |
— |
blood |
Human |
|
DAA2661 |
Hypomethylation of HOXB7 is positively correlated with age |
HOXB7 |
— |
blood |
Human |
|
DAA2662 |
Hypomethylation of HOXB8 is positively correlated with age |
HOXB8 |
— |
blood |
Human |
|
DAA2723 |
Hypomethylation of HSD3B7 is positively correlated with age |
HSD3B7 |
— |
blood |
Human |
|
DAA2725 |
Hypomethylation of IFI35 is positively correlated with age |
IFI35 |
— |
blood |
Human |
|
DAA2727 |
Hypomethylation of IPO8 is positively correlated with age |
IPO8 |
— |
blood |
Human |
|
DAA2728 |
Hypomethylation of ITGA2B is positively correlated with age |
ITGA2B |
— |
blood |
Human |
|
DAA2616 |
Hypomethylation of KCNJ8 is positively correlated with age |
KCNJ8 |
— |
blood |
Human |
|
DAA2656 |
Hypomethylation of LAG3 is positively correlated with age |
LAG3 |
— |
blood |
Human |
|
DAA2733 |
Hypomethylation of LAG3 is positively correlated with age |
LAG3 |
— |
blood |
Human |
|
DAA2718 |
Hypomethylation of LGP1 is positively correlated with age |
GHDC |
— |
blood |
Human |
|
DAA2734 |
Hypomethylation of LLGL2 is positively correlated with age |
LLGL2 |
— |
blood |
Human |
|
DAA2735 |
Hypomethylation of LPXN is positively correlated with age |
LPXN |
— |
blood |
Human |
|
DAA2614 |
Hypomethylation of LSAMP is positively correlated with age |
LSAMP |
— |
blood |
Human |
|
DAA2648 |
Hypomethylation of MAP3K5 is positively correlated with age |
MAP3K5 |
— |
blood |
Human |
|
DAA2737 |
Hypomethylation of MAP3K5 is positively correlated with age |
MAP3K5 |
— |
blood |
Human |
|
DAA2664 |
Hypomethylation of MAST4 is positively correlated with age |
MAST4 |
— |
blood |
Human |
|
DAA2617 |
Hypomethylation of MEIS1 is positively correlated with age |
MEIS1 |
— |
blood |
Human |
|
DAA2622 |
Hypomethylation of MGEA5 is positively correlated with age |
MGEA5 |
— |
blood |
Human |
|
DAA2663 |
Hypomethylation of MIR10A is positively correlated with age |
MIR10A |
— |
blood |
Human |
|
DAA2657 |
Hypomethylation of MLF2 is positively correlated with age |
MLF2 |
— |
blood |
Human |
|
DAA2738 |
Hypomethylation of MLLT11 is positively correlated with age |
MLLT11 |
— |
blood |
Human |
|
DAA2739 |
Hypomethylation of MRPL55 is positively correlated with age |
MRPL55 |
— |
blood |
Human |
|
DAA2740 |
Hypomethylation of MSRB2 is positively correlated with age |
MSRB2 |
— |
blood |
Human |
DAA2742 |
Hypomethylation of NCOR2 is positively correlated with age |
NCOR2 |
— |
blood |
Human |
|
DAA2743 |
Hypomethylation of NDUFS5 is positively correlated with age |
NDUFS5 |
— |
blood |
Human |
|
DAA2639 |
Hypomethylation of NOD2 is positively correlated with age |
NOD2 |
— |
blood |
Human |
|
DAA2746 |
Hypomethylation of NPDC1 is positively correlated with age |
NPDC1 |
— |
blood |
Human |
|
DAA2623 |
Hypomethylation of NPM3 is positively correlated with age |
NPM3 |
— |
blood |
Human |
|
DAA2748 |
Hypomethylation of OR2B6 is positively correlated with age |
OR2B6 |
— |
blood |
Human |
|
DAA2749 |
Hypomethylation of PARP3 is positively correlated with age |
PARP3 |
— |
blood |
Human |
|
DAA2651 |
Hypomethylation of PCDH9 is positively correlated with age |
PCDH9 |
— |
blood |
Human |
|
DAA2750 |
Hypomethylation of PDCD1LG2 is positively correlated with age |
PDCD1LG2 |
— |
blood |
Human |
|
DAA2752 |
Hypomethylation of PDZK1IP1 is positively correlated with age |
PDZK1IP1 |
— |
blood |
Human |
|
DAA2754 |
Hypomethylation of POMGNT1 is positively correlated with age |
POMGNT1 |
— |
blood |
Human |
|
DAA2756 |
Hypomethylation of PRKG2 is positively correlated with age |
PRKG2 |
— |
blood |
Human |
|
DAA2652 |
Hypomethylation of PRR5L is positively correlated with age |
PRR5L |
— |
blood |
Human |
|
DAA2758 |
Hypomethylation of PSME1 is positively correlated with age |
PSME1 |
— |
blood |
Human |
|
DAA2759 |
Hypomethylation of PTGDS is positively correlated with age |
PTGDS |
— |
blood |
Human |
|
DAA2658 |
Hypomethylation of PTMS is positively correlated with age |
PTMS |
— |
blood |
Human |
|
DAA2618 |
Hypomethylation of PTPRT is positively correlated with age |
PTPRT |
— |
blood |
Human |
|
DAA2644 |
Hypomethylation of RYR3 is positively correlated with age |
RYR3 |
— |
blood |
Human |
|
DAA2762 |
Hypomethylation of SAMD10 is positively correlated with age |
SAMD10 |
— |
blood |
Human |
|
DAA2763 |
Hypomethylation of SCAP is positively correlated with age |
SCAP |
— |
blood |
Human |
|
DAA2765 |
Hypomethylation of SCN7A is positively correlated with age |
SCN7A |
— |
blood |
Human |
|
DAA2766 |
Hypomethylation of SDS is positively correlated with age |
SDS |
— |
blood |
Human |
|
DAA2770 |
Hypomethylation of SNTB1 is positively correlated with age |
SNTB1 |
— |
blood |
Human |
|
DAA2613 |
Hypomethylation of SNTG1 is positively correlated with age |
SNTG1 |
— |
blood |
Human |
|
DAA2640 |
Hypomethylation of SNX20 is positively correlated with age |
SNX20 |
— |
blood |
Human |
DAA2676 |
Hypomethylation of SORBS2 is positively correlated with age |
SORBS2 |
— |
blood |
Human |
|
DAA2619 |
Hypomethylation of STPG1 is positively correlated with age |
STPG1 |
— |
blood |
Human |
|
DAA2637 |
Hypomethylation of TFG is positively correlated with age |
TFG |
— |
blood |
Human |
|
DAA2641 |
Hypomethylation of TIAL1 is positively correlated with age |
TIAL1 |
— |
blood |
Human |
|
DAA2653 |
Hypomethylation of TRAF6 is positively correlated with age |
TRAF6 |
— |
blood |
Human |
|
DAA2642 |
Hypomethylation of TRHDE is positively correlated with age |
TRHDE |
— |
blood |
Human |
|
DAA2624 |
Hypomethylation of TRPS1 is positively correlated with age |
TRPS1 |
— |
blood |
Human |
|
DAA2646 |
Hypomethylation of UBE2E3 is positively correlated with age |
UBE2E3 |
— |
blood |
Human |
|
DAA2643 |
Hypomethylation of VWF is positively correlated with age |
VWF |
— |
blood |
Human |
|
DAA2615 |
Hypomethylation of ZEB2 is positively correlated with age |
ZEB2 |
— |
blood |
Human |
|
DAA372 |
hypothetical gene supported by BC015790; BC041634 |
|
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA261 |
hypothetical LOC100126583 |
|
43.0% IncreaseGene Expression Level |
kidney |
Human |
|
DAA411 |
hypothetical LOC144438 |
|
4.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA320 |
hypothetical LOC202781 |
|
4.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA380 |
hypothetical LOC440993 |
|
10.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA295 |
hypothetical protein DKFZp586I1420 |
|
7.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2404 |
hypothetical protein LOC126353 decreases with age |
MISP |
16.3% DecreaseDNA Methylation |
dermis |
Human |
|
DAA2453 |
hypothetical protein LOC126353 decreases with age |
MISP |
24.8% DecreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA2458 |
hypothetical protein LOC146433 decreases with age |
IL34 |
27.7% DecreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA398 |
hypothetical protein LOC157860 |
|
15.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2439 |
hypothetical protein LOC283598 increases with age |
C14orf177 |
42.5% IncreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA260 |
hypothetical protein LOC284214 |
|
53.0% IncreaseGene Expression Level |
kidney |
Human |
|
DAA123 |
hypothetical protein LOC552889 |
|
3.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA890 |
IgM deposition in glomeruli |
— |
— |
glomerulus |
Human |
|
DAA259 |
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
IGJ |
60.0% IncreaseGene Expression Level |
kidney |
Human |
|
DAA285 |
immunoglobulin kappa variable 1-5 |
IGKV1-5 |
35.0% IncreaseGene Expression Level |
kidney |
Human |
|
DAA274 |
immunoglobulin lambda variable 3-25 |
IGLV3-25 |
46.0% IncreaseGene Expression Level |
kidney |
Human |
|
DAA284 |
immunoglobulin lambda variable 4-3 |
IGLV4-3 |
41.0% IncreaseGene Expression Level |
kidney |
Human |
|
DAA483 |
immunoglobulin-like and fibronectin type III domain containing 1 |
IGFN1 |
15.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2042 |
Increase in IgA and IgM |
— |
— |
oral cavity |
Human |
|
DAA108 |
inhibin, beta B |
INHBB |
17.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA112 |
inositol 1,4,5-trisphosphate 3-kinase A |
ITPKA |
24.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA113 |
inositol 1,4,5-trisphosphate 3-kinase B |
ITPKB |
15.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA414 |
inositol hexakisphosphate kinase 3 |
IP6K3 |
7.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA109 |
insulin receptor |
INSR |
8.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA111 |
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
ITGB1 |
7.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA2251 |
interleukin 18 (interferon-gamma-inducing factor) increases with age |
IL18 |
68.9% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2260 |
interleukin 18 (interferon-gamma-inducing factor) increases with age |
IL18 |
56.7% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA30 |
interleukin 33 |
IL33 |
47.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA2409 |
interleukin 34 decreases with age |
IL34 |
17.6% DecreaseDNA Methylation |
dermis |
Human |
|
DAA2120 |
IQ motif containing D increases with age |
IQCD |
56.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA110 |
iron-responsive element binding protein 2 |
IREB2 |
25.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA392 |
isoamyl acetate-hydrolyzing esterase 1 homolog (S. cerevisiae) |
IAH1 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2130 |
Janus kinase and microtubule interacting protein 3 increases with age |
JAKMIP3 |
100.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA402 |
junctophilin 1 |
JPH1 |
2.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA118 |
kelch domain containing 3 |
KLHDC3 |
26.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA502 |
kelch-like 31 (Drosophila) |
KLHL31 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA262 |
kelch-like 3 (Drosophila) |
KLHL3 |
14.0% DecreaseGene Expression Level |
kidney |
Human |
|
DAA119 |
kelch-like 9 (Drosophila) |
KLHL9 |
6.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA2422 |
keratin 6A decreases with age |
KRT6A |
16.7% DecreaseDNA Methylation |
dermis |
Human |
|
DAA363 |
KIAA0232 |
KIAA0232 |
2.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA115 |
KIAA0317 |
KIAA0317 |
4.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA505 |
KIAA1430 |
KIAA1430 |
7.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA116 |
KIAA1467 |
KIAA1467 |
6.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2118 |
KIAA1737 decreases with age |
KIAA1737 |
50.2% DecreaseGene Expression Level |
ovary |
Human |
|
DAA2095 |
kinesin family member 1B decreases with age |
KIF1B |
43.2% DecreaseGene Expression Level |
ovary |
Human |
|
DAA117 |
kinesin family member 3C |
KIF3C |
9.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA257 |
kininogen 1 |
KNG1 |
17.0% DecreaseGene Expression Level |
kidney |
Human |
|
DAA10 |
KN motif and ankyrin repeat domains 1 |
KANK1 |
16.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA345 |
Kruppel-like factor 13 |
KLF13 |
8.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA283 |
lactotransferrin |
LTF |
115.0% IncreaseGene Expression Level |
kidney |
Human |
|
DAA128 |
latent transforming growth factor beta binding protein 1 |
LTBP1 |
19.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA2425 |
lecithin-cholesterol acyltransferase precursor decreases with age |
LCAT |
18.6% DecreaseDNA Methylation |
dermis |
Human |
|
DAA121 |
legumain |
LGMN |
4.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA339 |
lemur tyrosine kinase 2 |
LMTK2 |
15.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA127 |
leucine-rich repeats and immunoglobulin-like domains 1 |
LRIG1 |
13.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA2533 |
Level of let-7a decreases with age |
MIRLET7A1 |
36.6% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2577 |
Level of let-7c increases with age |
MIRLET7C |
33.6% IncreasemiRNA Level |
T cell |
Human |
|
DAA2475 |
Level of let-7d decreases with age |
MIRLET7D |
25.8% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2559 |
Level of let-7f decreases with age |
MIRLET7F1 |
65.6% DecreasemiRNA Level |
T cell |
Human |
|
DAA2526 |
Level of let-7f decreases with age |
MIRLET7F1 |
34.5% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2476 |
Level of let-7g decreases with age |
MIRLET7G |
32.9% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2561 |
Level of let-7i decreases with age |
MIRLET7I |
46.9% DecreasemiRNA Level |
T cell |
Human |
|
DAA2503 |
Level of let-7i decreases with age |
MIRLET7I |
18.7% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2465 |
Level of miR-100 decreases with age |
MIR100 |
49.1% DecreasemiRNA Level |
foreskin |
Human
|
DAA2537 |
Level of miR-101 decreases with age |
MIR101-1 |
29.6% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2581 |
Level of miR-101 decreases with age |
MIR101-1 |
49.5% DecreasemiRNA Level |
T cell |
Human |
|
DAA2575 |
Level of miR-106b decreases with age |
MIR106B |
40.4% DecreasemiRNA Level |
T cell |
Human |
|
DAA2501 |
Level of miR-107 decreases with age |
MIR107 |
29.7% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2467 |
Level of miR-10a decreases with age |
MIR10A |
52.2% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2492 |
Level of miR-10b decreases with age |
MIR10B |
41.6% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2568 |
Level of miR-125a-5p decreases with age |
MIR125A |
48.2% DecreasemiRNA Level |
T cell |
Human |
|
DAA2517 |
Level of miR-125b decreases with age |
MIR125B1 |
30.5% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2504 |
Level of miR-126 decreases with age |
MIR126 |
33.1% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2499 |
Level of miR-126* decreases with age |
MIR126 |
32.3% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2471 |
Level of miR-130a decreases with age |
MIR130A |
44.6% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2464 |
Level of miR-144 increases with age |
MIR144 |
390.2% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2572 |
Level of miR-146b-5p increases with age |
MIR146B |
59.4% IncreasemiRNA Level |
T cell |
Human |
|
DAA2488 |
Level of miR-148b decreases with age |
MIR148B |
31.8% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2498 |
Level of miR-149 decreases with age |
MIR149 |
34.6% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2539 |
Level of miR-151-5p decreases with age |
MIR151A |
26.8% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2478 |
Level of miR-152 decreases with age |
MIR152 |
35.1% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2542 |
Level of miR-154* increases with age |
MIR154 |
67.7% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2553 |
Level of miR-15a decreases with age |
MIR15A |
78.0% DecreasemiRNA Level |
T cell |
Human |
|
DAA2506 |
Level of miR-15b decreases with age |
MIR15B |
28.2% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2578 |
Level of miR-15b decreases with age |
MIR15B |
29.4% DecreasemiRNA Level |
T cell |
Human |
|
DAA2551 |
Level of miR-17 decreases with age |
MIR17 |
63.1% DecreasemiRNA Level |
T cell |
Human |
|
DAA2519 |
Level of miR-181a decreases with age |
MIR181A1 |
40.7% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2522 |
Level of miR-183* increases with age |
MIR183 |
82.5% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2474 |
Level of miR-184 increases with age |
MIR184 |
52.1% IncreasemiRNA Level |
foreskin |
Human |
DAA2580 |
Level of miR-18b decreases with age |
MIR18B |
39.3% DecreasemiRNA Level |
T cell |
Human |
|
DAA2482 |
Level of miR-191 decreases with age |
MIR191 |
38.4% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2534 |
Level of miR-196a decreases with age |
MIR196A1 |
40.5% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2505 |
Level of miR-198 increases with age |
FSTL1 |
74.3% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2523 |
Level of miR-199a-3p/199b-3p decreases with age |
MIR199A1 |
39.9% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2532 |
Level of miR-199a-3p/199b-3p decreases with age |
MIR199A1 |
40.0% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2530 |
Level of miR-199a-5p decreases with age |
MIR199A1 |
26.5% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2513 |
Level of miR-199b-5p decreases with age |
MIR199B |
62.2% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2463 |
Level of miR-19a decreases with age |
MIR19A |
40.7% DecreasemiRNA Level |
mesenchymal stem cell |
Human |
|
DAA2563 |
Level of miR-19a decreases with age |
MIR19A |
49.0% DecreasemiRNA Level |
T cell |
Human |
|
DAA2510 |
Level of miR-19a decreases with age |
MIR19A |
24.6% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2548 |
Level of miR-19b decreases with age |
MIR19B1 |
63.5% DecreasemiRNA Level |
T cell |
Human |
|
DAA2485 |
Level of miR-200c decreases with age |
MIR200C |
35.6% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2579 |
Level of miR-206 decreases with age |
MIR206 |
47.4% DecreasemiRNA Level |
T cell |
Human |
|
DAA2571 |
Level of miR-20b decreases with age |
MIR20B |
53.3% DecreasemiRNA Level |
T cell |
Human |
|
DAA2511 |
Level of miR-210 decreases with age |
MIR210 |
21.8% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2557 |
Level of miR-212 decreases with age |
MIR212 |
66.0% DecreasemiRNA Level |
T cell |
Human |
|
DAA2493 |
Level of miR-214 decreases with age |
MIR214 |
27.1% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2547 |
Level of miR-21 decreases with age |
MIR21 |
83.6% DecreasemiRNA Level |
T cell |
Human |
|
DAA2549 |
Level of miR-23a increases with age |
MIR23A |
137.2% IncreasemiRNA Level |
T cell |
Human |
|
DAA2565 |
Level of miR-23b increases with age |
MIR23B |
32.8% IncreasemiRNA Level |
T cell |
Human |
|
DAA2518 |
Level of miR-26a decreases with age |
MIR26A1 |
27.5% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2558 |
Level of miR-27a decreases with age |
MIR27A |
47.7% DecreasemiRNA Level |
T cell |
Human |
|
DAA2573 |
Level of miR-27b decreases with age |
MIR27B |
31.7% DecreasemiRNA Level |
T cell |
Human |
|
DAA2521 |
Level of miR-28-5p decreases with age |
MIR28 |
38.1% DecreasemiRNA Level |
foreskin |
Human |
DAA2494 |
Level of miR-29a increases with age |
MIR29A |
30.4% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2552 |
Level of miR-29b decreases with age |
MIR29B1 |
57.3% DecreasemiRNA Level |
T cell |
Human |
|
DAA2566 |
Level of miR-29c decreases with age |
MIR29C |
29.5% DecreasemiRNA Level |
T cell |
Human |
|
DAA2486 |
Level of miR-30b decreases with age |
MIR30B |
43.0% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2484 |
Level of miR-30b* increases with age |
MIR30B |
59.5% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2520 |
Level of miR-30c decreases with age |
MIR30C1 |
43.2% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2470 |
Level of miR-30d decreases with age |
MIR30D |
40.7% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2483 |
Level of miR-30e decreases with age |
MIR30E |
33.2% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2555 |
Level of miR-30e decreases with age |
MIR30E |
73.8% DecreasemiRNA Level |
T cell |
Human |
|
DAA2489 |
Level of miR-30e* decreases with age |
MIR30E |
40.8% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2472 |
Level of miR-326 decreases with age |
MIR326 |
32.8% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2468 |
Level of miR-335 decreases with age |
MIR335 |
57.2% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2569 |
Level of miR-335 decreases with age |
MIR335 |
57.9% DecreasemiRNA Level |
T cell |
Human |
|
DAA2514 |
Level of miR-338-3p decreases with age |
MIR338 |
61.7% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2567 |
Level of miR-340 decreases with age |
MIR340 |
46.6% DecreasemiRNA Level |
T cell |
Human |
|
DAA2531 |
Level of miR-342-3p decreases with age |
MIR342 |
36.5% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2560 |
Level of miR-342-3p increases with age |
MIR342 |
57.5% IncreasemiRNA Level |
T cell |
Human |
|
DAA2541 |
Level of miR-361-5p decreases with age |
MIR361 |
24.9% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2496 |
Level of miR-374a decreases with age |
MIR374A |
36.1% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2480 |
Level of miR-374b decreases with age |
MIR374B |
37.9% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2524 |
Level of miR-376a decreases with age |
MIR376A1 |
31.3% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2495 |
Level of miR-381 increases with age |
MIR381 |
50.5% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2545 |
Level of miR-423-3p increases with age |
MIR423 |
33.8% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2500 |
Level of miR-424 decreases with age |
MIR424 |
39.2% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2546 |
Level of miR-432* increases with age |
MIR432 |
37.1% IncreasemiRNA Level |
foreskin |
Human |
DAA2515 |
Level of miR-451 increases with age |
MIR451A |
111.0% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2535 |
Level of miR-483-5p increases with age |
MIR483 |
92.2% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2527 |
Level of miR-486-5p increases with age |
MIR486 |
72.5% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2556 |
Level of miR-487b decreases with age |
MIR487B |
58.6% DecreasemiRNA Level |
T cell |
Human |
|
DAA2477 |
Level of miR-489 decreases with age |
MIR489 |
29.8% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2564 |
Level of miR-491-3p decreases with age |
MIR491 |
45.9% DecreasemiRNA Level |
T cell |
Human |
|
DAA2469 |
Level of miR-492 increases with age |
MIR492 |
83.9% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2508 |
Level of miR-494 increases with age |
MIR494 |
25.0% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2574 |
Level of miR-498 decreases with age |
MIR498 |
29.7% DecreasemiRNA Level |
T cell |
Human |
|
DAA2538 |
Level of miR-512-5p increases with age |
MIR512-1 |
26.0% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2544 |
Level of miR-518a-5p/527 increases with age |
MIR518A1 |
38.6% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2543 |
Level of miR-518c* increases with age |
MIR518C |
55.5% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2536 |
Level of miR-518d-5p/518f*/520c-5p/526a increases with age |
MIR518D |
41.4% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2462 |
Level of miR-519d decreases with age |
MIR519D |
44.7% DecreasemiRNA Level |
mesenchymal stem cell |
Human |
|
DAA2550 |
Level of miR-519d decreases with age |
MIR519D |
61.6% DecreasemiRNA Level |
T cell |
Human |
|
DAA2516 |
Level of miR-519e* increases with age |
MIR519E |
88.8% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2562 |
Level of miR-525-5p decreases with age |
MIR525 |
61.4% DecreasemiRNA Level |
T cell |
Human |
|
DAA2525 |
Level of miR-525-5p increases with age |
MIR525 |
102.5% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2502 |
Level of miR-526b increases with age |
MIR526B |
50.2% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2509 |
Level of miR-543 increases with age |
MIR543 |
40.7% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2473 |
Level of miR-583 increases with age |
MIR583 |
105.4% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2481 |
Level of miR-584 increases with age |
MIR584 |
40.9% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2570 |
Level of miR-590-5p decreases with age |
MIR590 |
55.8% DecreasemiRNA Level |
T cell |
Human |
|
DAA2487 |
Level of miR-602 increases with age |
MIR602 |
39.0% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2529 |
Level of miR-642 decreases with age |
MIR642A |
27.5% DecreasemiRNA Level |
foreskin |
Human
|
DAA2479 |
Level of miR-658 increases with age |
MIR658 |
65.7% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2554 |
Level of miR-668 increases with age |
MIR668 |
251.4% IncreasemiRNA Level |
T cell |
Human |
|
DAA2540 |
Level of miR-671-5p increases with age |
MIR671 |
45.9% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2497 |
Level of miR-675 increases with age |
MIR675 |
69.0% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2512 |
Level of miR-744 decreases with age |
MIR744 |
28.9% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2491 |
Level of miR-765 increases with age |
MIR765 |
117.2% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2528 |
Level of miR-96* increases with age |
MIR96 |
62.4% IncreasemiRNA Level |
foreskin |
Human |
|
DAA2507 |
Level of miR-98 decreases with age |
MIR98 |
18.9% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2576 |
Level of miR-98 decreases with age |
MIR98 |
43.8% DecreasemiRNA Level |
T cell |
Human |
|
DAA2466 |
Level of miR-99a decreases with age |
MIR99A |
49.9% DecreasemiRNA Level |
foreskin |
Human |
|
DAA2490 |
Level of miR-99b decreases with age |
MIR99B |
25.3% DecreasemiRNA Level |
foreskin |
Human |
|
DAA1998 |
Lipid oxidation increased with age in males |
— |
— |
skin |
Human |
|
DAA126 |
lipid phosphate phosphatase-related protein type 4 |
LPPR4 |
10.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA578 |
lipin 1 |
LPIN1 |
5.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA270 |
lipoprotein lipase |
LPL |
17.0% DecreaseGene Expression Level |
kidney |
Human |
|
DAA1987 |
Loss of CpG methylation in the promoter of TNF |
TNF |
— |
macrophage, leukocyte |
Human |
|
DAA2122 |
low density lipoprotein receptor class A domain containing 3 increases with age |
LDLRAD3 |
60.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA2396 |
L-pipecolic acid oxidase increases with age |
PIPOX |
22.8% IncreaseDNA Methylation |
dermis |
Human |
|
DAA2445 |
L-pipecolic acid oxidase increases with age |
PIPOX |
32.2% IncreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA2097 |
LSM5 homolog, U6 small nuclear RNA associated (S. cerevisiae) decreases with age |
LSM5 |
66.3% DecreaseGene Expression Level |
ovary |
Human |
|
DAA313 |
LUC7-like 3 (S. cerevisiae) |
LUC7L3 |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA120 |
lysosomal-associated membrane protein 2 |
LAMP2 |
21.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA290 |
lysozyme (renal amyloidosis) |
LYZ |
57.0% IncreaseGene Expression Level |
kidney |
Human |
|
DAA2086 |
MAD2L1 binding protein increases with age |
MAD2L1BP |
58.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA2327 |
major histocompatibility complex, class I, B increases with age |
HLA-B |
35.0% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2379 |
major histocompatibility complex, class I, B increases with age |
HLA-B |
39.0% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2341 |
major histocompatibility complex, class I, B increases with age |
HLA-B |
36.5% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2373 |
major histocompatibility complex, class I, B increases with age |
HLA-B |
44.0% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2376 |
major histocompatibility complex, class I, C increases with age |
HLA-C |
39.8% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2381 |
major histocompatibility complex, class I, C increases with age |
HLA-C |
32.8% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2382 |
major histocompatibility complex, class I, C increases with age |
HLA-C |
44.0% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2378 |
major histocompatibility complex, class I, C increases with age |
HLA-C |
37.0% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2328 |
major histocompatibility complex, class I, C increases with age |
HLA-C |
32.6% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2336 |
major histocompatibility complex, class I, C increases with age |
HLA-C |
37.7% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2342 |
major histocompatibility complex, class I, C increases with age |
HLA-C |
40.1% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2380 |
major histocompatibility complex, class I, C increases with age |
HLA-C |
56.5% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2374 |
major histocompatibility complex, class I, C increases with age |
HLA-C |
38.9% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2375 |
major histocompatibility complex, class I, C increases with age |
HLA-C |
37.8% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2377 |
major histocompatibility complex, class I, C increases with age |
HLA-C |
34.9% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2331 |
major histocompatibility complex, class I, E increases with age |
HLA-E |
39.2% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2339 |
major histocompatibility complex, class I, E increases with age |
HLA-E |
34.9% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2330 |
major histocompatibility complex, class I, E increases with age |
HLA-E |
58.3% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2329 |
major histocompatibility complex, class I, E increases with age |
HLA-E |
76.6% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2337 |
major histocompatibility complex, class I, E increases with age |
HLA-E |
43.9% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2338 |
major histocompatibility complex, class I, E increases with age |
HLA-E |
41.6% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2343 |
major histocompatibility complex, class I, E increases with age |
HLA-E |
61.2% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2345 |
major histocompatibility complex, class I, E increases with age |
HLA-E |
65.7% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2344 |
major histocompatibility complex, class I, E increases with age |
HLA-E |
76.9% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2346 |
major histocompatibility complex, class I, F increases with age |
HLA-F |
28.9% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2312 |
major histocompatibility complex, class II, DM alpha increases with age |
HLA-DMA |
221.5% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2354 |
major histocompatibility complex, class II, DR alpha increases with age |
HLA-DRA |
150.4% IncreaseGene Expression Level |
temporal lobe |
Human |
|
DAA2364 |
major histocompatibility complex, class II, DR alpha increases with age |
HLA-DRA |
303.7% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2369 |
major histocompatibility complex, class II, DR alpha increases with age |
HLA-DRA |
135.3% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2137 |
major histocompatibility complex, class II, DR beta 1 increases with age |
HLA-DRB1 |
83.0% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2135 |
major histocompatibility complex, class II, DR beta 1 increases with age |
HLA-DRB1 |
193.5% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2360 |
major histocompatibility complex, class II, DR beta 1 increases with age |
HLA-DRB1 |
204.2% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2136 |
major histocompatibility complex, class II, DR beta 1 increases with age |
HLA-DRB1 |
90.3% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2370 |
major histocompatibility complex, class II, DR beta 1 increases with age |
HLA-DRB1 |
84.8% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2365 |
major histocompatibility complex, class II, DR beta 1 increases with age |
HLA-DRB1 |
111.1% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2366 |
major histocompatibility complex, class II, DR beta 4 increases with age |
HLA-DRB4 |
100.4% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2371 |
major histocompatibility complex, class II, DR beta 4 increases with age |
HLA-DRB4 |
88.5% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2361 |
major histocompatibility complex, class II, DR beta 4 increases with age |
HLA-DRB4 |
177.7% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2372 |
major histocompatibility complex, class II, DR beta 5 increases with age |
HLA-DRB5 |
64.1% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2367 |
major histocompatibility complex, class II, DR beta 5 increases with age |
HLA-DRB5 |
95.8% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2362 |
major histocompatibility complex, class II, DR beta 5 increases with age |
HLA-DRB5 |
184.0% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2164 |
major histocompatibility complex, class II, DR beta 6 increases with age |
HLA-DRB6 |
33.5% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2163 |
major histocompatibility complex, class II, DR beta 6 increases with age |
HLA-DRB6 |
150.2% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2335 |
major histocompatibility complex, class I-related increases with age |
MR1 |
46.6% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2350 |
major histocompatibility complex, class I-related increases with age |
MR1 |
32.2% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2349 |
major histocompatibility complex, class I-related increases with age |
MR1 |
22.4% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA472 |
makorin ring finger protein 1 |
MKRN1 |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA550 |
makorin ring finger protein pseudogene 5 |
MKRNP5 |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA424 |
malate dehydrogenase 1, NAD (soluble) |
MDH1 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA135 |
malate dehydrogenase 1, NAD (soluble) |
MDH1 |
4.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA298 |
malate dehydrogenase 2, NAD (mitochondrial) |
MDH2 |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA409 |
malectin |
MLEC |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA431 |
malic enzyme 2, NAD(+)-dependent, mitochondrial |
ME2 |
5.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA136 |
malic enzyme 3, NADP(+)-dependent, mitochondrial |
ME3 |
5.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA351 |
mannan-binding lectin serine peptidase 2 |
MASP2 |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA266 |
matrix metallopeptidase 7 (matrilysin, uterine) |
MMP7 |
23.0% IncreaseGene Expression Level |
kidney |
Human |
|
DAA86 |
mechanistic target of rapamycin (serine/threonine kinase) |
MTOR |
7.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA139 |
megalencephalic leukoencephalopathy with subcortical cysts 1 |
MLC1 |
10.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA394 |
melanoma antigen family D, 2 |
MAGED2 |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA143 |
metallothionein 1E |
MT1E |
10.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA518 |
metallothionein 2A |
MT2A |
6.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2421 |
metastasis suppressor 1 decreases with age |
MTSS1 |
16.5% DecreaseDNA Methylation |
dermis |
Human |
|
DAA555 |
metaxin 2 |
MTX2 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA430 |
methyltransferase like 2B |
METTL2B |
5.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2348 |
MHC class I polypeptide-related sequence A increases with age |
MICA |
37.9% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2165 |
MHC class I polypeptide-related sequence A increases with age |
MICA |
39.5% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2340 |
MHC class I polypeptide-related sequence B increases with age |
MICB |
39.9% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2449 |
microfibrillar associated protein 5 decreases with age |
MFAP5 |
46.4% DecreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA2400 |
microfibrillar associated protein 5 decreases with age |
MFAP5 |
15.0% DecreaseDNA Methylation |
dermis |
Human |
|
DAA2131 |
microRNA host gene 1 (non-protein coding) decreases with age |
MIR17HG |
41.2% DecreaseGene Expression Level |
ovary |
Human |
|
DAA2056 |
MicroRNA let-7b expression upregulated |
— |
— |
skeletal muscle |
Human |
|
DAA2057 |
MicroRNA let-7e expression upregulated |
— |
— |
skeletal muscle |
Human |
|
DAA129 |
microtubule-associated protein 2 |
MAP2 |
20.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA338 |
microtubule-associated protein, RP/EB family, member 2 |
MAPRE2 |
5.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA133 |
microtubule-associated protein tau |
MAPT |
14.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2002 |
miR-103 expression decreases with age |
MIR103A1 |
— |
blood, immune system |
Human |
DAA2604 |
miR-106a decreases with age |
MIR106A |
98.7% DecreasemiRNA Level |
blood |
Human |
|
DAA2003 |
miR-107 expression decreases with age |
MIR107 |
— |
blood, immune system |
Human |
|
DAA2603 |
miR-1248 decreases with age |
MIR1248 |
— |
blood |
Human |
|
DAA2605 |
miR-126 decreases with age |
MIR126 |
93.3% DecreasemiRNA Level |
blood |
Human |
|
DAA2004 |
miR-128 expression decreases with age |
MIR128-1 |
— |
blood, immune system |
Human |
|
DAA2005 |
miR-128 expression decreases with age |
MIR128-2 |
— |
blood, immune system |
Human |
|
DAA2006 |
miR-130a expression decreases with age |
MIR130A |
— |
blood, immune system |
Human |
|
DAA2607 |
miR-144* decreases with age |
MIR144 |
85.9% DecreasemiRNA Level |
blood |
Human |
|
DAA2012 |
miR-1538 expression decreases with age |
MIR1538 |
— |
blood, immune system |
Human |
|
DAA2007 |
miR-155 expression decreases with age |
MIR155 |
— |
blood, immune system |
Human |
|
DAA2602 |
miR-181a-5p decreases with age |
MIR181A2 |
— |
blood |
Human |
|
DAA2601 |
miR-181a-5p decreases with age |
MIR181A1 |
— |
blood |
Human |
|
DAA2608 |
miR-18a decreases with age |
MIR18A |
89.8% DecreasemiRNA Level |
blood |
Human |
|
DAA2606 |
miR-20a decreases with age |
MIR20A |
94.2% DecreasemiRNA Level |
blood |
Human |
|
DAA2010 |
miR-221 expression decreases with age |
MIR221 |
— |
blood, immune system |
Human |
|
DAA2009 |
miR-24 expression decreases with age |
MIR24-2 |
— |
blood, immune system |
Human |
|
DAA2008 |
miR-24 expression decreases with age |
MIR24-1 |
— |
blood, immune system |
Human |
|
DAA2612 |
miR-320b increases with age |
MIR320B2 |
1049.9% IncreasemiRNA Level |
blood |
Human |
|
DAA2611 |
miR-320b increases with age |
MIR320B1 |
1049.9% IncreasemiRNA Level |
blood |
Human |
|
DAA2610 |
miR-320d increases with age |
MIR320D2 |
529.9% IncreasemiRNA Level |
blood |
Human |
|
DAA2609 |
miR-320d increases with age |
MIR320D1 |
529.9% IncreasemiRNA Level |
blood |
Human |
|
DAA2011 |
miR-496 expression decreases with age |
MIR496 |
— |
blood, immune system |
Human |
|
DAA334 |
mitochondrial fission factor |
MFF |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA439 |
mitochondrial intermediate peptidase |
MIPEP |
5.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA451 |
mitochondrial ribosomal protein L12 |
MRPL12 |
6.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA315 |
mitochondrial ribosomal protein L18 |
MRPL18 |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA141 |
mitochondrial ribosomal protein L33 |
MRPL33 |
4.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA562 |
mitochondrial ribosomal protein L41 |
MRPL41 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2116 |
mitochondrial ribosomal protein L43 increases with age |
MRPL43 |
151.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA493 |
mitochondrial ribosomal protein L48 |
MRPL48 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA142 |
mitochondrial ribosomal protein S12 |
MRPS12 |
5.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA519 |
mitochondrial ribosomal protein S15 |
MRPS15 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA465 |
mitochondrial ribosomal protein S22 |
MRPS22 |
1.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA528 |
mitochondrial ribosomal protein S24 |
MRPS24 |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA511 |
mitochondrial ribosomal protein S30 |
MRPS30 |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA361 |
mitochondrial ribosomal protein S7 |
MRPS7 |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA131 |
mitogen-activated protein kinase 1 |
MAPK1 |
17.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA579 |
mitogen-activated protein kinase 6 |
MAPK6 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA132 |
mitogen-activated protein kinase 9 |
MAPK9 |
15.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA130 |
mitogen-activated protein kinase kinase 1 |
MAP2K1 |
7.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA456 |
mitogen-activated protein kinase kinase kinase 15 |
MAP3K15 |
8.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA311 |
mitogen-activated protein kinase kinase kinase kinase 3 |
MAP4K3 |
5.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2085 |
mitogen-activated protein kinase kinase kinase kinase 4 increases with age |
MAP4K4 |
69.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA455 |
mixed lineage kinase domain-like |
MLKL |
7.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA140 |
monocyte to macrophage differentiation-associated |
MMD |
7.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA401 |
MORN repeat containing 5 |
MORN5 |
20.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA1224 |
MTHFR methylation decrease |
— |
— |
prefrontal cortex |
Human |
|
DAA70 |
multiple EGF-like-domains 8 |
MEGF8 |
27.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA134 |
muscleblind-like 2 (Drosophila) |
MBNL2 |
12.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2072 |
myelin basic protein increases with age |
MBP |
139.0% IncreaseGene Expression Level |
ovary |
Human
|
DAA2230 |
myeloid differentiation primary response gene (88) increases with age |
MYD88 |
54.8% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2242 |
myeloid differentiation primary response gene (88) increases with age |
MYD88 |
58.7% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2216 |
myeloid differentiation primary response gene (88) increases with age |
MYD88 |
59.3% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA1104 |
Myogenic Differentiation 1 |
MYOD1 |
IncreaseDNA Methylation |
temporal lobe |
Human |
|
DAA1103 |
Myogenic Differentiation 1 |
MYOD1 |
IncreaseDNA Methylation |
pons |
Human |
|
DAA1101 |
Myogenic Differentiation 1 |
MYOD1 |
IncreaseDNA Methylation |
cerebellum |
Human |
|
DAA1102 |
Myogenic Differentiation 1 |
MYOD1 |
IncreaseDNA Methylation |
frontal lobe |
Human |
|
DAA340 |
myomesin (M-protein) 2, 165kDa |
MYOM2 |
5.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA312 |
myosin, heavy chain 8, skeletal muscle, perinatal |
MYH8 |
20.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA145 |
myosin VI |
MYO6 |
18.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA144 |
myosin X |
MYO10 |
20.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA355 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa |
NDUFA10 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA499 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12 |
NDUFA12 |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA292 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa |
NDUFA9 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA492 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa |
NDUFB3 |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA386 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4, 15kDa |
NDUFB4 |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA366 |
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa |
NDUFC1 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA437 |
NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa |
NDUFV2 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2000 |
NAD(+) levels decrease with age |
— |
— |
skin |
Human |
|
DAA2074 |
natural killer-tumor recognition sequence decreases with age |
NKTR |
37.5% DecreaseGene Expression Level |
ovary |
Human |
|
DAA2434 |
nerve growth factor; beta polypeptide precursor decreases with age |
NGF |
22.5% DecreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA2385 |
nerve growth factor; beta polypeptide precursor increases with age |
NGF |
19.3% IncreaseDNA Methylation |
dermis |
Human |
|
DAA154 |
N-ethylmaleimide-sensitive factor |
NSF |
10.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA146 |
N-ethylmaleimide-sensitive factor attachment protein, alpha |
NAPA |
13.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA147 |
N-ethylmaleimide-sensitive factor attachment protein, gamma |
NAPG |
23.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA326 |
neural precursor cell expressed, developmentally down-regulated 1 |
NEDD1 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA153 |
neurexin 1 |
NRXN1 |
15.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA410 |
neuroblastoma breakpoint family, member 10 |
NBPF10 |
2.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA148 |
neurocalcin delta |
NCALD |
9.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA152 |
neurogranin (protein kinase C substrate, RC3) |
NRGN |
4.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA155 |
neurotensin receptor 2 |
NTSR2 |
7.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA580 |
neutrophil cytosolic factor 1C pseudogene |
NCF1C |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2073 |
NGFI-A binding protein 1 (EGR1 binding protein 1) decreases with age |
NAB1 |
47.9% DecreaseGene Expression Level |
ovary |
Human |
|
DAA485 |
nicotinamide N-methyltransferase |
NNMT |
17.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA279 |
nicotinamide N-methyltransferase |
NNMT |
40.0% IncreaseGene Expression Level |
kidney |
Human |
|
DAA543 |
nicotinamide nucleotide adenylyltransferase 3 |
NMNAT3 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA463 |
nicotinamide nucleotide transhydrogenase |
NNT |
5.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA150 |
NIMA (never in mitosis gene a)-related kinase 7 |
NEK7 |
17.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA151 |
NK2 homeobox 2 |
NKX2-2 |
14.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA2249 |
NLR family, pyrin domain containing 1 decreases with age |
NLRP1 |
29.4% DecreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2265 |
NLR family, pyrin domain containing 1 decreases with age |
NLRP1 |
24.8% DecreaseGene Expression Level |
parietal lobe |
Human |
|
DAA549 |
non-protein coding RNA 116 |
NCRNA00116 |
5.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA149 |
Norrie disease (pseudoglioma) |
NDP |
9.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA157 |
nuclear fragile X mental retardation protein interacting protein 1 |
NUFIP1 |
24.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2081 |
nuclear receptor subfamily 1, group H, member 2 increases with age |
NR1H2 |
77.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA158 |
nuclear transport factor 2-like export factor 2 |
NXT2 |
22.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA391 |
nucleolar and coiled-body phosphoprotein 1 |
NOLC1 |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2094 |
nucleoporin like 2 increases with age |
NUPL2 |
59.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA156 |
nudix (nucleoside diphosphate linked moiety X)-type motif 21 |
NUDT21 |
28.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA160 |
olfactomedin 1 |
OLFM1 |
5.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA162 |
olfactory receptor, family 2, subfamily H, member 2 |
OR2H2 |
16.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2420 |
olfactory receptor; family 5; subfamily V; member 1 increases with age |
OR5V1 |
15.3% IncreaseDNA Methylation |
dermis |
Human |
|
DAA161 |
oligodendrocyte lineage transcription factor 2 |
OLIG2 |
12.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA526 |
origin recognition complex, subunit 4-like (yeast) |
ORC4L |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA159 |
ornithine decarboxylase antizyme 1 |
OAZ1 |
4.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA164 |
osteoclast stimulating factor 1 |
OSTF1 |
29.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA163 |
oxysterol binding protein |
OSBP |
8.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA165 |
p21 protein (Cdc42/Rac)-activated kinase 1 |
PAK1 |
23.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA524 |
paired immunoglobin-like type 2 receptor beta |
PILRB |
6.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2268 |
pannexin 1 decreases with age |
PANX1 |
41.6% DecreaseGene Expression Level |
temporal lobe |
Human |
|
DAA2247 |
pannexin 1 decreases with age |
PANX1 |
59.9% DecreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2258 |
pannexin 1 decreases with age |
PANX1 |
50.0% DecreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2351 |
Pannexin 2 decreases with age |
PANX2 |
8.1% DecreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2352 |
Pannexin 2 decreases with age |
PANX2 |
19.1% DecreaseGene Expression Level |
hippocampus |
Human |
|
DAA2353 |
Pannexin 2 decreases with age |
PANX2 |
16.5% DecreaseGene Expression Level |
temporal lobe |
Human |
|
DAA264 |
paraoxonase 3 |
PON3 |
13.0% DecreaseGene Expression Level |
kidney |
Human |
|
DAA449 |
paraspeckle component 1 |
PSPC1 |
2.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA1999 |
PARP activity increases with age in males |
PARP1 |
— |
skin |
Human |
|
DAA348 |
parvin, gamma |
PARVG |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA481 |
PCTAIRE protein kinase 1 |
PCTK1 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA168 |
PCTAIRE protein kinase 2 |
PCTK2 |
19.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2407 |
PDZ and LIM domain 2 isoform 3 decreases with age |
PDLIM2 |
17.3% DecreaseDNA Methylation |
dermis |
Human |
|
DAA2456 |
PDZ and LIM domain 2 isoform 3 increases with age |
PDLIM2 |
43.9% IncreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA170 |
PDZ and LIM domain 3 |
PDLIM3 |
22.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA322 |
PDZ domain containing ring finger 3 |
PDZRN3 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA413 |
peptidase (mitochondrial processing) alpha |
PMPCA |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA433 |
peptidylprolyl isomerase A (cyclophilin A) |
PPIA |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA446 |
peptidylprolyl isomerase A (cyclophilin A) |
PPIA |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA389 |
peptidylprolyl isomerase C (cyclophilin C) |
PPIC |
5.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA459 |
peptidylprolyl isomerase F |
PPIF |
5.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA458 |
pericentriolar material 1 |
PCM1 |
2.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA417 |
peripheral myelin protein 22 |
PMP22 |
6.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA559 |
peroxidasin homolog (Drosophila)-like |
PXDNL |
20.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA185 |
peroxiredoxin 6 |
PRDX6 |
11.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA2096 |
PHD finger protein 3 decreases with age |
PHF3 |
69.3% DecreaseGene Expression Level |
ovary |
Human |
|
DAA175 |
phosphatidylinositol glycan anchor biosynthesis, class C |
PIGC |
5.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2076 |
phosphatidylinositol transfer protein, alpha increases with age |
PITPNA |
75.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA176 |
phosphatidylinositol transfer protein, beta |
PITPNB |
17.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA169 |
phosphodiesterase 4D, cAMP-specific (phosphodiesterase E3 dunce homolog, Drosophila) |
PDE4D |
21.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA352 |
phospholipase A2, group XIIA |
PLA2G12A |
8.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA177 |
phospholipase C-like 2 |
PLCL2 |
10.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA178 |
phospholipase D family, member 3 |
PLD3 |
10.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA1077 |
Pipecolic Acid Oxidase |
PIPOX |
IncreaseDNA Methylation |
cerebellum |
Human |
|
DAA1078 |
Pipecolic Acid Oxidase |
PIPOX |
IncreaseDNA Methylation |
frontal lobe |
Human |
|
DAA1079 |
Pipecolic Acid Oxidase |
PIPOX |
IncreaseDNA Methylation |
pons |
Human |
|
DAA1080 |
Pipecolic Acid Oxidase |
PIPOX |
IncreaseDNA Methylation |
temporal lobe |
Human |
|
DAA180 |
plexin B1 |
PLXNB1 |
11.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA191 |
poliovirus receptor-related 3 |
PVRL3 |
20.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA581 |
polymerase (DNA-directed), delta interacting protein 3 |
POLDIP3 |
5.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2075 |
poly(rC) binding protein 1 increases with age |
PCBP1 |
59.0% IncreaseGene Expression Level |
ovary |
Human |
AA114 |
potassium inwardly-rectifying channel, subfamily J, member 9 |
KCNJ9 |
27.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA454 |
potassium voltage-gated channel, subfamily G, member 2 |
KCNG2 |
10.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA181 |
POU class 6 homeobox 1 |
POU6F1 |
4.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA457 |
prion protein |
PRNP |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA179 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 |
PLOD2 |
24.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA172 |
profilin 2 |
PFN2 |
4.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA125 |
programmed cell death 4 (neoplastic transformation inhibitor) |
PDCD4 |
12.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA1094 |
Prostaglandin E Receptor 3 (subtype EP3) |
PTGER3 |
IncreaseDNA Methylation |
frontal lobe |
Human |
|
DAA1095 |
Prostaglandin E Receptor 3 (subtype EP3) |
PTGER3 |
IncreaseDNA Methylation |
pons |
Human |
|
DAA1096 |
Prostaglandin E Receptor 3 (subtype EP3) |
PTGER3 |
IncreaseDNA Methylation |
temporal lobe |
Human |
|
DAA1093 |
Prostaglandin E Receptor 3 (subtype EP3) |
PTGER3 |
IncreaseDNA Methylation |
cerebellum |
Human |
|
DAA59 |
prostate androgen-regulated mucin-like protein 1 |
PARM1 |
17.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2430 |
prostate transmembrane protein, androgen induced 1 decreases with age |
PMEPA1 |
20.8% DecreaseDNA Methylation |
dermis |
Human |
|
DAA189 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 |
PSMD8 |
8.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA173 |
protein inhibitor of activated STAT, 2 |
PIAS2 |
10.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA174 |
protein inhibitor of activated STAT, 3 |
PIAS3 |
10.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA407 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
PRKAA2 |
4.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA186 |
protein kinase C, beta |
PRKCB |
11.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2446 |
protein kinase C binding protein 1 isoform a increases with age |
ZMYND8 |
19.9% IncreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA187 |
protein kinase C, gamma |
PRKCG |
12.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA188 |
protein kinase C, zeta |
PRKCZ |
12.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2447 |
protein kinase N1 isoform 2 increases with age |
PKN1 |
27.7% IncreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA2398 |
protein kinase N1 isoform 2 increases with age |
PKN1 |
17.6% IncreaseDNA Methylation |
dermis |
Human |
|
DAA167 |
protein-L-isoaspartate (D-aspartate) O-methyltransferase |
PCMT1 |
12.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA182 |
protein phosphatase 1E (PP2C domain containing) |
PPM1E |
17.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA183 |
protein phosphatase 2 (formerly 2A), regulatory subunit A, alpha isoform |
PPP2R1A |
6.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA184 |
protein phosphatase 5, catalytic subunit |
PPP5C |
7.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA397 |
protein tyrosine phosphatase, non-receptor type 3 |
PTPN3 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA190 |
protein tyrosine phosphatase, receptor type, E |
PTPRE |
39.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA360 |
protein tyrosine phosphatase, receptor type, J |
PTPRJ |
11.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA369 |
PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae) |
PRPF8 |
2.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2416 |
pyridoxal (pyridoxine, vitamin B6) kinase increases with age |
PDXK |
17.2% IncreaseDNA Methylation |
dermis |
Human |
|
DAA464 |
pyruvate dehydrogenase complex, component X |
PDHX |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA516 |
pyruvate dehydrogenase (lipoamide) alpha 1 |
PDHA1 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA395 |
pyruvate dehydrogenase (lipoamide) beta |
PDHB |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA192 |
quaking homolog, KH domain RNA binding (mouse) |
QKI |
8.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA512 |
RAB10, member RAS oncogene family |
RAB10 |
2.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA428 |
RAB11A, member RAS oncogene family |
RAB11A |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA193 |
RAB2A, member RAS oncogene family |
RAB2A |
11.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA194 |
RAB3A, member RAS oncogene family |
RAB3A |
11.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA203 |
radixin |
RDX |
13.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA422 |
Ral GTPase activating protein, alpha subunit 1 (catalytic) |
RALGAPA1 |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2429 |
RANBP2-like and GRIP domain containing 5 isoform 2 decreases with age |
RGPD5 |
20.4% DecreaseDNA Methylation |
dermis |
Human |
|
DAA2077 |
RAN, member RAS oncogene family decreases with age |
RAN |
40.1% DecreaseGene Expression Level |
ovary |
Human |
|
DAA197 |
RAP2A, member of RAS oncogene family |
RAP2A |
28.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA200 |
Ras association (RalGDS/AF-6) domain family member 2 |
RASSF2 |
18.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA199 |
Ras protein-specific guanine nucleotide-releasing factor 1 |
RASGRF1 |
22.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA278 |
Ras-related GTP binding D |
RRAGD |
14.0% DecreaseGene Expression Level |
kidney |
Human |
|
DAA196 |
receptor (G protein-coupled) activity modifying protein 1 |
RAMP1 |
16.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA206 |
regucalcin (senescence marker protein-30) |
RGN |
15.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA207 |
regulator of G-protein signaling 20 |
RGS20 |
25.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA208 |
regulator of G-protein signaling 4 |
RGS4 |
16.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA1222 |
RELN promoter methylation increase |
RELN |
— |
brain, cerebral cortex |
Human |
|
DAA204 |
replication factor C (activator 1) 5, 36.5kDa |
RFC5 |
7.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA213 |
reticulon 1 |
RTN1 |
8.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA214 |
reticulon 4 |
RTN4 |
8.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA201 |
retinoblastoma binding protein 5 |
RBBP5 |
9.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA198 |
retinoic acid receptor responder (tazarotene induced) 2 |
RARRES2 |
9.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA425 |
retinoid X receptor, gamma |
RXRG |
6.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA202 |
retinol binding protein 4, plasma |
RBP4 |
13.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA276 |
Rh family, C glycoprotein |
RHCG |
16.0% DecreaseGene Expression Level |
kidney |
Human |
|
DAA210 |
Rho family GTPase 1 |
RND1 |
10.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA1088 |
Rhomboid Domain Containing 1 |
RHBDD1 |
IncreaseDNA Methylation |
temporal lobe |
Human |
|
DAA1085 |
Rhomboid Domain Containing 1 |
RHBDD1 |
IncreaseDNA Methylation |
cerebellum |
Human |
|
DAA1086 |
Rhomboid Domain Containing 1 |
RHBDD1 |
IncreaseDNA Methylation |
frontal lobe |
Human |
|
DAA1087 |
Rhomboid Domain Containing 1 |
RHBDD1 |
IncreaseDNA Methylation |
pons |
Human |
|
DAA209 |
Rho-related BTB domain containing 3 |
RHOBTB3 |
25.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA336 |
ribosomal protein L3 |
RPL3 |
2.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA332 |
ribosomal protein S27-like |
RPS27L |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA370 |
ring finger protein 103 |
RNF103 |
4.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2129 |
ring finger protein 144B decreases with age |
RNF144B |
70.2% DecreaseGene Expression Level |
ovary |
Human |
|
DAA107 |
ring finger protein 19B |
RNF19B |
11.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA211 |
RNA binding motif protein 38 |
RBM38 |
12.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA440 |
RNA binding motif protein 39 |
RBM39 |
2.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA294 |
RNA terminal phosphate cyclase domain 1 |
RTCD1 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2128 |
RPTOR independent companion of MTOR, complex 2 decreases with age |
RICTOR |
35.1% DecreaseGene Expression Level |
ovary |
Human |
|
DAA212 |
RUN domain containing 3A |
RUNDC3A |
5.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2231 |
S100 calcium binding protein A8 increases with age |
S100A8 |
1228.2% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2243 |
S100 calcium binding protein A8 increases with age |
S100A8 |
921.4% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2206 |
S100 calcium binding protein A8 increases with age |
S100A8 |
530.6% IncreaseGene Expression Level |
temporal lobe |
Human |
|
DAA2217 |
S100 calcium binding protein A8 increases with age |
S100A8 |
1115.4% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2244 |
S100 calcium binding protein A9 increases with age |
S100A9 |
92.8% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2232 |
S100 calcium binding protein A9 increases with age |
S100A9 |
229.0% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA215 |
S100 calcium binding protein B |
S100B |
11.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA2101 |
saccharopine dehydrogenase (putative) decreases with age |
SCCPDH |
46.5% DecreaseGene Expression Level |
ovary |
Human |
|
DAA1099 |
Schlafen Family Member 11 |
SLFN11 |
IncreaseDNA Methylation |
pons |
Human |
|
DAA1097 |
Schlafen Family Member 11 |
SLFN11 |
IncreaseDNA Methylation |
cerebellum |
Human |
|
DAA1098 |
Schlafen Family Member 11 |
SLFN11 |
IncreaseDNA Methylation |
frontal lobe |
Human |
|
DAA1100 |
Schlafen Family Member 11 |
SLFN11 |
IncreaseDNA Methylation |
temporal lobe |
Human |
|
DAA2426 |
secretory leukocyte peptidase inhibitor precursor decreases with age |
SLPI |
18.6% DecreaseDNA Methylation |
dermis |
Human |
|
DAA582 |
selenium binding protein 1 |
SELENBP1 |
7.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA219 |
selenium binding protein 1 |
SELENBP1 |
7.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA2387 |
selenium binding protein 1 decreases with age |
SELENBP1 |
15.7% DecreaseDNA Methylation |
dermis |
Human |
|
DAA2436 |
selenium binding protein 1 decreases with age |
SELENBP1 |
20.8% DecreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA390 |
selenocysteine lyase |
SCLY |
6.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA222 |
selenophosphate synthetase 1 |
SEPHS1 |
12.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA563 |
selenoprotein P, plasma, 1 |
SEPP1 |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2092 |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B increases with age |
SEMA4B |
58.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA220 |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
SEMA6A |
8.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA2399 |
semaphorin 3B isoform 2 precursor increases with age |
SEMA3B |
16.1% IncreaseDNA Methylation |
dermis |
Human |
|
DAA2448 |
semaphorin 3B isoform 2 precursor increases with age |
SEMA3B |
19.1% IncreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA2402 |
serine (or cysteine) proteinase inhibitor; clade A (alpha-1 antiproteinase; antitrypsin); member 12 decreases with age |
SERPINA12 |
15.2% DecreaseDNA Methylation |
dermis |
Human |
|
DAA2451 |
serine (or cysteine) proteinase inhibitor; clade A (alpha-1 antiproteinase; antitrypsin); member 12 increases with age |
SERPINA12 |
52.7% IncreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA229 |
serine peptidase inhibitor, Kunitz type, 2 |
SPINT2 |
3.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA282 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
SERPINA5 |
11.0% DecreaseGene Expression Level |
kidney |
Human |
|
DAA223 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member |
SERPINF1 |
7.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA216 |
seryl-tRNA synthetase |
SARS |
10.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA441 |
SH3-domain kinase binding protein 1 |
SH3KBP1 |
5.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA420 |
sialidase 3 (membrane sialidase) |
NEU3 |
8.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2133 |
similar to hCG2020539; family with sequence similarity 60, member A; similar to family with sequence similarity 60, member A decreases with age |
LOC728592 |
56.1% DecreaseGene Expression Level |
ovary |
Human |
|
DAA452 |
sirtuin (silent mating type information regulation 2 homolog) 5 (S. cerevisiae) |
SIRT5 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2418 |
Sma- and Mad-related protein 2 increases with age |
SMAD2 |
16.5% IncreaseDNA Methylation |
dermis |
Human |
|
DAA2071 |
SMAD family member 2 decreases with age |
SMAD2 |
58.0% DecreaseGene Expression Level |
ovary |
Human |
|
DAA527 |
small EDRK-rich factor 2 |
SERF2 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA484 |
small nuclear ribonucleoprotein 70kDa (U1) |
SNRNP70 |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA560 |
SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae) |
SUMO2 |
2.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA217 |
sodium channel, voltage-gated, type II, beta |
SCN2B |
50.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA268 |
solute carrier family 12 (sodium/chloride transporters), member 3 |
SLC12A3 |
16.0% DecreaseGene Expression Level |
kidney |
Human |
|
DAA225 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7 |
SLC17A7 |
9.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA533 |
solute carrier family 25, member 30 |
SLC25A30 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA226 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
SLC25A4 |
9.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA561 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
SLC25A4 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA412 |
solute carrier family 25 (mitochondrial carrier, Aralar), member 12 |
SLC25A12 |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA531 |
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3 |
SLC25A3 |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA166 |
solute carrier family 2 (facilitated glucose transporter), member 3 pseudogene 1 |
SLC2A3P1 |
17.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA307 |
solute carrier family 38, member 1 |
SLC38A1 |
7.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2105 |
solute carrier family 41, member 3 increases with age |
SLC41A3 |
52.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA461 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 3 |
SLC7A3 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2098 |
solute carrier organic anion transporter family, member 3A1 increases with age |
SLCO3A1 |
92.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA331 |
sorting and assembly machinery component 50 homolog (S. cerevisiae) |
SAMM50 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA228 |
sorting nexin 3 |
SNX3 |
5.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA902 |
specific activities of enzymes are reduced |
— |
— |
kidney |
Human |
|
DAA2079 |
spectrin, beta, non-erythrocytic 1 decreases with age |
SPTBN1 |
48.5% DecreaseGene Expression Level |
ovary |
Human |
|
DAA2432 |
sperm associated antigen 7 decreases with age |
SPAG7 |
26.2% DecreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA2383 |
sperm associated antigen 7 increases with age |
SPAG7 |
26.1% IncreaseDNA Methylation |
dermis |
Human |
|
DAA301 |
sperm associated antigen 9 |
SPAG9 |
4.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA317 |
spermidine/spermine N1-acetyl transferase-like 1 |
SATL1 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA224 |
S-phase kinase-associated protein 1 |
SKP1 |
4.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA67 |
sphingosine-1-phosphate receptor 1 |
S1PR1 |
27.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA467 |
splicing factor, arginine/serine-rich 5 |
SFRS5 |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA534 |
splicing factor, arginine/serine-rich 6 |
SFRS6 |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA429 |
splicing factor proline/glutamine-rich (polypyrimidine tract binding protein associated) |
SFPQ |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA230 |
spondin 1, extracellular matrix protein |
SPON1 |
21.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA357 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltran |
ST6GALNAC2 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA468 |
STAM binding protein |
STAMBP |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2414 |
Stannin increases with age |
SNN |
19.5% IncreaseDNA Methylation |
dermis |
Human |
|
DAA286 |
StAR-related lipid transfer (START) domain containing 8 |
STARD8 |
14.0% DecreaseGene Expression Level |
kidney |
Human |
|
DAA231 |
stathmin-like 2 |
STMN2 |
6.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA432 |
STE20-related kinase adaptor beta |
STRADB |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA323 |
sterile alpha motif domain containing 9-like |
SAMD9L |
4.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA325 |
succinate-CoA ligase, alpha subunit |
SUCLG1 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA486 |
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa |
SDHC |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA221 |
SUMO1/sentrin/SMT3 specific peptidase 3 |
SENP3 |
3.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA227 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
SMARCA2 |
3.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA233 |
synapsin II |
SYN2 |
29.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2084 |
synaptosomal-associated protein, 23kDa decreases with age |
SNAP23 |
51.5% DecreaseGene Expression Level |
ovary |
Human |
|
DAA234 |
synaptotagmin I |
SYT1 |
4.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2389 |
syncoilin; intermediate filament 1 decreases with age |
SYNC |
16.0% DecreaseDNA Methylation |
dermis |
Human |
|
DAA2438 |
syncoilin; intermediate filament 1 increases with age |
SYNC |
21.4% IncreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA218 |
syndecan 2 |
SDC2 |
25.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA387 |
talin 2 |
TLN2 |
6.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA1201 |
TCF4 exon 1 methylation increases |
TCF4 |
IncreaseDNA Methylation |
gastric mucosa |
Human |
|
DAA2089 |
teashirt zinc finger homeobox 1 increases with age |
TSHZ1 |
57.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA673 |
telomere length in hematopoietic stem cells |
— |
— |
hematopoietic stem cells |
Human |
|
DAA1986 |
telomere shortening |
— |
— |
leukocyte |
Human |
|
DAA849 |
telomere shortening |
— |
— |
liver |
Human |
|
DAA989 |
telomere shortening |
— |
— |
lymphocytes |
Human |
|
DAA901 |
telomere shortening |
— |
— |
kidney |
Human |
|
DAA959 |
telomere shortening |
— |
— |
naïve T cell |
Human |
|
DAA2256 |
Thioredoxin interacting protein increases with age |
TXNIP |
143.1% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2246 |
Thioredoxin interacting protein increases with age |
TXNIP |
250.2% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2245 |
Thioredoxin interacting protein increases with age |
TXNIP |
277.8% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2267 |
Thioredoxin interacting protein increases with age |
TXNIP |
130.7% IncreaseGene Expression Level |
temporal lobe |
Human |
|
DAA2257 |
Thioredoxin interacting protein increases with age |
TXNIP |
124.8% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2266 |
Thioredoxin interacting protein increases with age |
TXNIP |
146.6% IncreaseGene Expression Level |
temporal lobe |
Human |
|
DAA522 |
thioredoxin-like 4A |
TXNL4A |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA476 |
thiosulfate sulfurtransferase (rhodanese) |
TST |
5.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA238 |
Thy-1 cell surface antigen |
THY1 |
7.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA381 |
thyroid hormone receptor interactor 12 |
TRIP12 |
2.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2218 |
toll interacting protein decreases with age |
TOLLIP |
61.5% DecreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2220 |
toll interacting protein decreases with age |
TOLLIP |
33.4% DecreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2234 |
toll interacting protein decreases with age |
TOLLIP |
57.8% DecreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2233 |
toll interacting protein decreases with age |
TOLLIP |
59.5% DecreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2219 |
toll interacting protein decreases with age |
TOLLIP |
53.6% DecreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2235 |
toll interacting protein decreases with age |
TOLLIP |
36.3% DecreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2208 |
toll-like receptor 1 increases with age |
TLR1 |
87.3% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2222 |
toll-like receptor 1 increases with age |
TLR1 |
39.8% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2237 |
toll-like receptor 2 increases with age |
TLR2 |
155.6% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2205 |
toll-like receptor 2 increases with age |
TLR2 |
185.1% IncreaseGene Expression Level |
temporal lobe |
Human |
|
DAA2223 |
toll-like receptor 2 increases with age |
TLR2 |
189.1% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2209 |
toll-like receptor 3 increases with age |
TLR3 |
53.0% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2226 |
toll-like receptor 4 increases with age |
TLR4 |
82.2% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2210 |
toll-like receptor 4 increases with age |
TLR4 |
69.4% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2239 |
toll-like receptor 4 increases with age |
TLR4 |
150.9% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2211 |
toll-like receptor 4 increases with age |
TLR4 |
65.2% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2240 |
toll-like receptor 4 increases with age |
TLR4 |
83.7% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2227 |
toll-like receptor 4 increases with age |
TLR4 |
46.0% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2224 |
toll-like receptor 4 increases with age |
TLR4 |
115.5% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2238 |
toll-like receptor 4 increases with age |
TLR4 |
148.4% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2225 |
toll-like receptor 4 increases with age |
TLR4 |
114.7% IncreaseGene Expression Level |
parietal lobe |
Human |
|
AA2241 |
toll-like receptor 5 increases with age |
TLR5 |
48.7% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2212 |
toll-like receptor 5 increases with age |
TLR5 |
96.4% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2228 |
toll-like receptor 5 increases with age |
TLR5 |
69.2% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2229 |
toll-like receptor 7 increases with age |
TLR7 |
38.8% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2213 |
toll-like receptor 7 increases with age |
TLR7 |
94.7% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2214 |
toll-like receptor 7 increases with age |
TLR7 |
56.5% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2215 |
Toll-like receptor 8 increases with age |
TLR8 |
39.7% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA400 |
trafficking protein particle complex 1 |
TRAPPC1 |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA337 |
transcription elongation regulator 1 |
TCERG1 |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA236 |
transcription factor 12 |
TCF12 |
7.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA494 |
transcription factor 25 (basic helix-loop-helix) |
TCF25 |
2.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA235 |
transgelin 3 |
TAGLN3 |
5.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA237 |
transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) |
TGM2 |
18.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA319 |
translin-associated factor X |
TSNAX |
4.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA239 |
translocase of inner mitochondrial membrane 17 homolog A (yeast) |
TIMM17A |
13.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2410 |
transmembrane 4 superfamily member 3 decreases with age |
TSPAN8 |
17.9% DecreaseDNA Methylation |
dermis |
Human |
|
DAA2459 |
transmembrane 4 superfamily member 3 increases with age |
TSPAN8 |
36.4% IncreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA2112 |
transmembrane protein 135 decreases with age |
TMEM135 |
67.5% DecreaseGene Expression Level |
ovary |
Human |
|
DAA523 |
transmembrane protein 167B |
TMEM167B |
4.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA495 |
transmembrane protein 19 |
TMEM19 |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2109 |
transmembrane protein 33 decreases with age |
TMEM33 |
63.9% DecreaseGene Expression Level |
ovary |
Human |
|
DAA537 |
transmembrane protein 59-like |
TMEM59L |
8.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA1067 |
transporter activity decreases |
— |
— |
blood brain barrier |
Human |
|
DAA2093 |
TRIO and F-actin binding protein increases with age |
TRIOBP |
73.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA583 |
tripartite motif-containing 15 |
TRIM15 |
18.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA205 |
tripartite motif-containing 27 |
TRIM27 |
5.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA566 |
TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae) |
TRMT5 |
2.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA324 |
tRNA methyltransferase 11-2 homolog (S. cerevisiae) |
TRMT112 |
4.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA242 |
trophoblast glycoprotein |
TPBG |
13.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2099 |
tropomodulin 3 (ubiquitous) decreases with age |
TMOD3 |
35.9% DecreaseGene Expression Level |
ovary |
Human |
|
DAA244 |
TSPY-like 2 |
TSPYL2 |
14.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2117 |
TSPY-like 5 decreases with age |
TSPYL5 |
45.4% DecreaseGene Expression Level |
ovary |
Human |
|
DAA243 |
tubulin polymerization promoting protein |
TPPP |
21.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA416 |
tubulin polymerization-promoting protein family member 3 |
TPPP3 |
48.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2408 |
tumor necrosis factor receptor superfamily; member 17 decreases with age |
TNFRSF17 |
17.6% DecreaseDNA Methylation |
dermis |
Human |
|
DAA2457 |
tumor necrosis factor receptor superfamily; member 17 increases with age |
TNFRSF17 |
18.8% IncreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA241 |
tumor necrosis factor receptor superfamily, member 21 |
TNFRSF21 |
18.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2417 |
tumor suppressing subtransferable candidate 5 increases with age |
SLC22A18 |
16.9% IncreaseDNA Methylation |
dermis |
Human |
|
DAA277 |
tyrosinase-related protein 1 |
TYRP1 |
21.0% DecreaseGene Expression Level |
kidney |
Human |
|
DAA252 |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
YWHAZ |
10.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA510 |
U2 small nuclear RNA auxiliary factor 1 |
U2AF1 |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA556 |
ubiquinol-cytochrome c reductase complex (7.2 kD) |
UCRC |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA497 |
ubiquinol-cytochrome c reductase core protein II |
UQCRC2 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA525 |
ubiquinol-cytochrome c reductase hinge protein |
UQCRH |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA585 |
ubiquinol-cytochrome c reductase hinge protein |
UQCRH |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA584 |
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 |
UQCRFS1 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2090 |
ubiquitination factor E4B (UFD2 homolog, yeast) decreases with age |
UBE4B |
43.8% DecreaseGene Expression Level |
ovary |
Human |
|
DAA2080 |
ubiquitin-conjugating enzyme E2D 2 (UBC4/5 homolog, yeast) decreases with age |
UBE2D2 |
48.2% DecreaseGene Expression Level |
ovary |
Human |
|
DAA491 |
ubiquitin-conjugating enzyme E2E 2 (UBC4/5 homolog, yeast) |
UBE2E2 |
5.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2115 |
ubiquitin specific peptidase 42 increases with age |
USP42 |
60.0% IncreaseGene Expression Level |
ovary |
Human
|
DAA375 |
ubiquitin specific peptidase 6 (Tre-2 oncogene) |
USP6 |
5.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA1105 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
B3GALT6 |
IncreaseDNA Methylation |
cerebellum |
Human |
|
DAA1108 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
B3GALT6 |
IncreaseDNA Methylation |
temporal lobe |
Human |
|
DAA1106 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
B3GALT6 |
IncreaseDNA Methylation |
frontal lobe |
Human |
|
DAA1107 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
B3GALT6 |
IncreaseDNA Methylation |
pons |
Human |
|
DAA2106 |
uridine-cytidine kinase 1-like 1 increases with age |
UCKL1 |
86.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA384 |
vacuolar protein sorting 13 homolog C (S. cerevisiae) |
VPS13C |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2104 |
vacuolar protein sorting 13 homolog C (S. cerevisiae) decreases with age |
VPS13C |
58.7% DecreaseGene Expression Level |
ovary |
Human |
|
DAA423 |
vascular endothelial growth factor B |
VEGFB |
6.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA50 |
versican |
VCAN |
20.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA517 |
very low density lipoprotein receptor |
VLDLR |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA245 |
vesicle-associated membrane protein 2 (synaptobrevin 2) |
VAMP2 |
4.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA246 |
vesicle-associated membrane protein 3 (cellubrevin) |
VAMP3 |
7.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA565 |
vesicle transport through interaction with t-SNAREs homolog 1B (yeast) |
VTI1B |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA248 |
vimentin |
VIM |
11.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA249 |
visinin-like 1 |
VSNL1 |
6.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA247 |
voltage-dependent anion channel 1 |
VDAC1 |
10.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2070 |
von Willebrand factor A domain containing 5A decreases with age |
VWA5A |
56.0% DecreaseGene Expression Level |
ovary |
Human |
|
DAA195 |
v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein) |
RALB |
7.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2078 |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) increases with age |
RELA |
60.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA250 |
WD repeat and SOCS box-containing 2 |
WSB2 |
5.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA436 |
WD repeat domain 12 |
WDR12 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2391 |
WNT1 inducible signaling pathway protein 2 precursor decreases with age |
WISP2 |
17.7% DecreaseDNA Methylation |
dermis |
Human |
|
DAA2440 |
WNT1 inducible signaling pathway protein 2 precursor decreases with age |
WISP2 |
23.5% DecreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA251 |
WW domain containing transcription regulator 1 |
WWTR1 |
24.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA353 |
xeroderma pigmentosum, complementation group C |
XPC |
7.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA586 |
xeroderma pigmentosum, complementation group C |
XPC |
6.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA255 |
zer-1 homolog (C. elegans) |
ZER1 |
16.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2113 |
zinc finger and BTB domain containing 10 decreases with age |
ZBTB10 |
59.4% DecreaseGene Expression Level |
ovary |
Human |
|
DAA330 |
zinc finger and BTB domain containing 4 |
ZBTB4 |
2.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA26 |
zinc finger, CCHC domain containing 24 |
ZCCHC24 |
15.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA513 |
zinc finger, FYVE domain containing 20 |
ZFYVE20 |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA60 |
zinc finger, MIZ-type containing 2 |
ZMIZ2 |
17.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2397 |
zinc finger, MYND-type containing 8 increases with age |
ZMYND8 |
19.5% IncreaseDNA Methylation |
dermis |
Human |
|
DAA2091 |
zinc finger protein 238 decreases with age |
ZBTB18 |
39.0% DecreaseGene Expression Level |
ovary |
Human |
|
DAA2127 |
zinc finger protein 25 decreases with age |
ZNF25 |
51.5% DecreaseGene Expression Level |
ovary |
Human |
|
DAA232 |
zinc finger protein 280A |
ZNF280A |
10.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA388 |
zinc finger protein 36, C3H type-like 1 |
ZFP36L1 |
6.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2121 |
zinc finger protein 3 homolog (mouse) increases with age |
ZFP3 |
51.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA254 |
zinc finger protein 507 |
ZNF507 |
43.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA2427 |
zinc finger protein 536 decreases with age |
ZNF536 |
19.1% DecreaseDNA Methylation |
dermis |
Human |
|
DAA2386 |
zinc finger protein 549 increases with age |
ZNF549 |
16.0% IncreaseDNA Methylation |
dermis |
Human |
|
DAA2435 |
zinc finger protein 549 increases with age |
ZNF549 |
19.3% IncreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA2107 |
zinc finger protein 770 decreases with age |
ZNF770 |
48.7% DecreaseGene Expression Level |
ovary |
Human |
|
DAA2102 |
zinc finger RNA binding protein increases with age |
ZFR |
150.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA253 |
zinc fingers and homeoboxes 2 |
ZHX2 |
20.0% IncreaseGene Expression Level |
brain |
Human |
|